<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">EXCLI J</journal-id>
      <journal-title>EXCLI Journal</journal-title>
      <issn pub-type="epub">1611-2156</issn>
      <publisher>
        <publisher-name>Leibniz Research Centre for Working Environment and Human Factors</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">2013-622</article-id>
      <article-id pub-id-type="pii">Doc1020</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Editorial material</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Improved genotyping of N-acetyltransferase 2: role of the ultra-slow acetylators</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Blaszkewicz</surname>
            <given-names>Meinolf</given-names>
          </name>
          <xref ref-type="corresp" rid="COR1">&#x0002a;</xref>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>Leibniz Research Centre for Working Environment and Human Factors, Dortmund&#x2F;Germany</aff>
      <author-notes>
        <corresp id="COR1">*To whom correspondence should be addressed: Meinolf Blaszkewicz, Leibniz Research Centre for Working Environment and Human Factors, Dortmund/Germany, E-mail: <email>Blaszkewicz@ifado.de</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>05</day>
        <month>12</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <volume>12</volume>
      <fpage>1020</fpage>
	  <lpage>1023</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>12</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 Blaszkewicz</copyright-statement>
        <copyright-year>2013</copyright-year>
       <license license-type="open-access" xlink:href="http://www.excli.de/documents/assignment_of_rights.pdf">
		<p>This is an Open Access article distributed under the following Assignment of Rights http://www.excli.de/documents/assignment_of_rights.pdf. You are free to copy, distribute and transmit the work, provided the original author and source are credited.</p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.excli.de/vol12/Blaszkewicz_05122013_proof.pdf">This article is available from http://www.excli.de/vol12/Blaszkewicz_05122013_proof.pdf</self-uri>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>⁯⁯⁯</title><p>N-acetyltransferase 2 polymorphisms are of high relevance in clinical toxicology (L&#xFC;ck et al., 2009[<xref ref-type="bibr" rid="R29">29</xref>]; Bing et al., 2011[<xref ref-type="bibr" rid="R4">4</xref>]; Costa et al., 2012[<xref ref-type="bibr" rid="R9">9</xref>]). The slow acetylator genotype of NAT2 has been demonstrated to be associated with an increased risk of anti-tuberculosis drug-induced liver damage (Cai et al., 2012[<xref ref-type="bibr" rid="R7">7</xref>]; Lv et al., 2012[<xref ref-type="bibr" rid="R30">30</xref>]; An et al., 2012[<xref ref-type="bibr" rid="R2">2</xref>]; Ben Mahmoud et al., 2012[<xref ref-type="bibr" rid="R3">3</xref>]; Bose et al., 2011[<xref ref-type="bibr" rid="R6">6</xref>]). Moreover, many urinary bladder carcinogens are substrates of NAT2 (Golka et al., 1996[<xref ref-type="bibr" rid="R16">16</xref>]; 2002[<xref ref-type="bibr" rid="R15">15</xref>]; Vineis et al., 2001[<xref ref-type="bibr" rid="R44">44</xref>]; Hung et al., 2004[<xref ref-type="bibr" rid="R25">25</xref>]; Moore et al., 2011[<xref ref-type="bibr" rid="R31">31</xref>]). Large meta-analyses have clearly shown an association between slow acetylation genotypes and increased risk of bladder cancer (Garcia-Closas et al., 2005[<xref ref-type="bibr" rid="R14">14</xref>]; 2011[<xref ref-type="bibr" rid="R13">13</xref>]; Sanderson et al., 2007[<xref ref-type="bibr" rid="R34">34</xref>]; Ag&#xFA;ndez et al., 2008[<xref ref-type="bibr" rid="R1">1</xref>]; Hein, 2002[<xref ref-type="bibr" rid="R20">20</xref>], 2006[<xref ref-type="bibr" rid="R21">21</xref>], 2009[<xref ref-type="bibr" rid="R22">22</xref>]; Hein and Doll, 2012[<xref ref-type="bibr" rid="R23">23</xref>][<xref ref-type="bibr" rid="R24">24</xref>]). However, at the level of individual studies the results remain controversial. Of 46 studies included into one of the recent meta-analysis 35 did not reach statistical significance (Moore et al., 2011[<xref ref-type="bibr" rid="R31">31</xref>]).</p><p>To clarify the situation a recent study has been performed to identify the role of &#x27;extreme&#x27; genotypes (Selinski et al., 2013[<xref ref-type="bibr" rid="R36">36</xref>]). This study is based on a population of 344 individuals that have been phenotyped by the caffeine test (Blaszkewicz, 2004[<xref ref-type="bibr" rid="R5">5</xref>]; Hakooz, 2009[<xref ref-type="bibr" rid="R18">18</xref>]; Jetter et al., 2009[<xref ref-type="bibr" rid="R26">26</xref>]). This test quantitatively determines the activity of NAT2 <italic>in vivo</italic>. A subgroup with an &#x60;ultra-slow&#xB4; <italic>in vivo</italic> metabolism of caffeine was identified.</p><p>Interestingly, these individuals with the ultra-slow NAT2 phenotype carried several slow acetylator alleles and could be identified as &#x2A;6A&#x2F;&#x2A;6A, &#x2A;6A&#x2F;&#x2A;7B and &#x2A;7B&#x2F;&#x2A;7B genotypes. This combination of slow alleles, the &#x27;ultra-slow genotype&#x27; was further tested in 1,712 bladder cancer cases and 2,020 controls. Remarkably, individuals with the &#x27;ultra-slow&#x27; genotype showed an increased odds ratio for bladder cancer risk (OR&#x3D;1.31, P&#x3D;0.012) whereas the slow acetylators in general were not significantly associated with cancer risk.</p><p>Currently, a huge number of studies is performed to understand the association between genetic variations and phenotype (Daly, 2013[<xref ref-type="bibr" rid="R10">10</xref>]; Stewart and Marchan, 2012[<xref ref-type="bibr" rid="R41">41</xref>]; Partosch et al., 2013[<xref ref-type="bibr" rid="R32">32</xref>]; Sobin et al., 2011[<xref ref-type="bibr" rid="R40">40</xref>]; Tumer et al., 2012[<xref ref-type="bibr" rid="R42">42</xref>]; Zeller et al., 2012[<xref ref-type="bibr" rid="R45">45</xref>]; Escobar-Garc&#xED;a et al., 2012[<xref ref-type="bibr" rid="R11">11</xref>]). A special focus are drug metabolizing enzymes and their role in carcinogenesis (Chen et al., 2012[<xref ref-type="bibr" rid="R8">8</xref>]; Hanioka et al., 2011[<xref ref-type="bibr" rid="R19">19</xref>]; Santovito et al., 2011[<xref ref-type="bibr" rid="R35">35</xref>]; Fujihara et al., 2011[<xref ref-type="bibr" rid="R12">12</xref>]; Lankisch et al., 2008[<xref ref-type="bibr" rid="R27">27</xref>]; Ulusoy et al., 2007[<xref ref-type="bibr" rid="R43">43</xref>]). Genome-wide association studies have identified to which degree genetic variants influence bladder cancer risk (Golka et al., 2011[<xref ref-type="bibr" rid="R17">17</xref>]; Selinski et al., 2011[<xref ref-type="bibr" rid="R37">37</xref>], 2012[<xref ref-type="bibr" rid="R38">38</xref>][<xref ref-type="bibr" rid="R39">39</xref>]; Safarinejad et al., 2011[<xref ref-type="bibr" rid="R33">33</xref>]; Lehmann et al., 2010[<xref ref-type="bibr" rid="R28">28</xref>]). However, most of these approaches considered only the genotype in relation to disease. The present study (Selinski et al., 2013[<xref ref-type="bibr" rid="R36">36</xref>]) demonstrates the importance of understanding the association of haplotypes with enzyme activity and the relevance of extreme phenotypes.</p></sec>
  </body>
  <back>
    <ref-list>
      <ref id="R1">
        <label>1</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Ag&#xFA;ndez</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Golka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mart&#xED;nez</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Selinski</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Blaszkewicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Garc&#xED;a-Mart&#xED;n</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Unraveling ambiguous NAT2 genotyping data</article-title>
          <source>Clin Chem</source>
          <year>2008</year>
          <volume>54</volume>
          <fpage>1390</fpage>
          <lpage>1394</lpage>
        </citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>An</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>XQ</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>ZY</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>JX</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients</article-title>
          <source>Clin Exp Pharmacol Physiol</source>
          <year>2012</year>
          <volume>39</volume>
          <fpage>535</fpage>
          <lpage>543</lpage>
        </citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Ben Mahmoud</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ghozzi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kamoun</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hakim</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hachicha</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hammami</surname>
              <given-names>S</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis</article-title>
          <source>Pathol Biol (Paris)</source>
          <year>2012</year>
          <volume>60</volume>
          <fpage>324</fpage>
          <lpage>330</lpage>
        </citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Bing</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Xiaomeia</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jinhenga</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Gene dose effect of NAT2 variants on the pharmacokinetics of isoniazid and acetylisoniazid in healthy Chinese subjects</article-title>
          <source>Drug Metabol Drug Interact</source>
          <year>2011</year>
          <volume>26</volume>
          <fpage>113</fpage>
          <lpage>118</lpage>
        </citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Blaszkewicz</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Angerer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>T</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>N-Acetyltransferase 2 (phenotyping: caffeine test)</article-title>
          <source>Analyses of hazardous substances in biological materials, Vol 9. Special issue: Markers of susceptibility</source>
          <year>2004</year>
          <publisher-loc>Weinheim</publisher-loc>
          <publisher-name>Wiley-VCH</publisher-name>
          <fpage>165</fpage>
          <lpage>182</lpage>
        </citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Bose</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Sarma</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Medhi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Husain</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Kar</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Role of polymorphic N-acetyl transferase 2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis</article-title>
          <source>J Gastroenterol Hepatol</source>
          <year>2011</year>
          <volume>26</volume>
          <fpage>312</fpage>
          <lpage>318</lpage>
        </citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Cai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis</article-title>
          <source>PLoS One</source>
          <year>2012</year>
          <volume>7</volume>
          <issue>10</issue>
          <fpage>e47769</fpage>
        </citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Chen</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Kuo</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>ZY</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Elevated risk of hypertension induced by arsenic exposure in Taiwanese rural residents: possible effects of manganese superoxide dismutase (MnSOD) and 8-oxoguanine DNA glycosylase (OGG1) genes</article-title>
          <source>Arch Toxicol</source>
          <year>2012</year>
          <volume>86</volume>
          <fpage>869</fpage>
          <lpage>878</lpage>
        </citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Costa</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Magno</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Santana</surname>
              <given-names>CV</given-names>
            </name>
            <name>
              <surname>Konstantinovas</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>M</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs</article-title>
          <source>Mol Diagn Ther</source>
          <year>2012</year>
          <volume>16</volume>
          <fpage>241</fpage>
          <lpage>250</lpage>
        </citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Daly</surname>
              <given-names>AK</given-names>
            </name>
          </person-group>
          <article-title>Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms</article-title>
          <source>Arch Toxicol</source>
          <year>2013</year>
          <volume>87</volume>
          <fpage>407</fpage>
          <lpage>420</lpage>
        </citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Escobar-Garc&#xED;a</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Del Razo</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Sanchez-Pe&#xF1;a</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Mandeville</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Lopez-Campos</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Escudero-Lourdes</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Association of glutathione S-transferase &#x3A9; 1-1 polymorphisms (A140D and E208K) with the expression of interleukin-8 (IL-8), transforming growth factor beta (TGF-&#x3B2;), and apoptotic protease-activating factor 1 (Apaf-1) in humans chronically exposed to arsenic in drinking water</article-title>
          <source>Arch Toxicol</source>
          <year>2012</year>
          <volume>86</volume>
          <fpage>857</fpage>
          <lpage>868</lpage>
        </citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Fujihara</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yasuda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yuasa</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Panduro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kunito</surname>
              <given-names>T</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Genetic variants associated with arsenic metabolism within human arsenic (&#x2B;3 oxidation state) methyltransferase show wide variation across multiple populations</article-title>
          <source>Arch Toxicol</source>
          <year>2011</year>
          <volume>85</volume>
          <fpage>119</fpage>
          <lpage>125</lpage>
        </citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Garc&#xED;a-Closas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hein</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Silverman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Malats</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yeager</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>K</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background</article-title>
          <source>Pharmacogenet Genomics</source>
          <year>2011</year>
          <volume>21</volume>
          <fpage>231</fpage>
          <lpage>236</lpage>
        </citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Garc&#xED;a-Closas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Malats</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Silverman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dosemeci</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kogevinas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hein</surname>
              <given-names>DW</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses</article-title>
          <source>Lancet</source>
          <year>2005</year>
          <volume>366</volume>
          <issue>9486</issue>
          <fpage>649</fpage>
          <lpage>659</lpage>
        </citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Golka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Prior</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Blaszkewicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bolt</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences</article-title>
          <source>Toxicol Lett</source>
          <year>2002</year>
          <volume>128</volume>
          <fpage>229</fpage>
          <lpage>241</lpage>
        </citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Golka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Prior</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Blaszkewicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cascorbi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sch&#xF6;ps</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Kierfeld</surname>
              <given-names>G</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany</article-title>
          <source>Scand J Work Environ Health</source>
          <year>1996</year>
          <volume>22</volume>
          <fpage>332</fpage>
          <lpage>338</lpage>
        </citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Golka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Selinski</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lehmann</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Blaszkewicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marchan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ickstadt</surname>
              <given-names>K</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Genetic variants in urinary bladder cancer: collective power of the &#x22;wimp SNPs&#x22;</article-title>
          <source>Arch Toxicol</source>
          <year>2011</year>
          <volume>85</volume>
          <fpage>539</fpage>
          <lpage>554</lpage>
        </citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Hakooz</surname>
              <given-names>NM</given-names>
            </name>
          </person-group>
          <article-title>Caffeine metabolic ratios for the in vivo evaluation of CYP1A2, N-acetyltransferase 2, xanthine oxidase and CYP2A6 enzymatic activities</article-title>
          <source>Curr Drug Metab</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>329</fpage>
          <lpage>338</lpage>
        </citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Hanioka</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Oka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nagaoka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ikushiro</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Narimatsu</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation</article-title>
          <source>Arch Toxicol</source>
          <year>2011</year>
          <volume>85</volume>
          <fpage>1373</fpage>
          <lpage>1381</lpage>
        </citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Hein</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis</article-title>
          <source>Mutat Re</source>
          <year>2002</year>
          <volume>506-507</volume>
          <fpage>65</fpage>
          <lpage>77</lpage>
        </citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Hein</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk</article-title>
          <source>Oncogene</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>1649</fpage>
          <lpage>1658</lpage>
        </citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Hein</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine</article-title>
          <source>Expert Opin Drug Metab Toxicol</source>
          <year>2009</year>
          <volume>5</volume>
          <fpage>353</fpage>
          <lpage>366</lpage>
        </citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Hein</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Doll</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>A four-SNP NAT2 genotyping panel recommended to infer human acetylator phenotype</article-title>
          <source>Pharmacogenomics</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>855</fpage>
        </citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Hein</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Doll</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes</article-title>
          <source>Pharmacogenomics</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>31</fpage>
          <lpage>41</lpage>
        </citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Hung</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Boffetta</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Malaveille</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hautefeuille</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Donato</surname>
              <given-names>F</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population</article-title>
          <source>Int J Cancer</source>
          <year>2004</year>
          <volume>110</volume>
          <fpage>598</fpage>
          <lpage>604</lpage>
        </citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Jetter</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kinzig</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rodamer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tomalik-Scharte</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>S&#xF6;rgel</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fuhr</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected&#x3F; Eur J Clin Pharmacol</article-title>
          <year>2009</year>
          <volume>65</volume>
          <fpage>411</fpage>
          <lpage>417</lpage>
        </citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Lankisch</surname>
              <given-names>TO</given-names>
            </name>
            <name>
              <surname>Gillman</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Erichsen</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Ehmer</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Kalthoff</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Freiberg</surname>
              <given-names>N</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Aryl hydrocarbon receptor-mediated regulation of the human estrogen and bile acid UDP-glucuronosyltransferase 1A3 gene</article-title>
          <source>Arch Toxicol</source>
          <year>2008</year>
          <volume>82</volume>
          <fpage>573</fpage>
          <lpage>582</lpage>
        </citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Lehmann</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Selinski</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Blaszkewicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Orlich</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ovsiannikov</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Moormann</surname>
              <given-names>O</given-names>
            </name>
            <etal />
          </person-group>
          <article-title xml:lang="de">Rs710521</article-title>
          <trans-title>A on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk</trans-title>
          <source>Arch Toxicol</source>
          <year>2010</year>
          <volume>84</volume>
          <fpage>967</fpage>
          <lpage>978</lpage>
        </citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>L&#xFC;ck</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kinzig</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jetter</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fuhr</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>S&#xF6;rgel</surname>
            </name>
          </person-group>
          <article-title>Mesalazine pharmacokinetics and NAT2 phenotype</article-title>
          <source>Eur J Clin Pharmacol</source>
          <year>2009</year>
          <volume>65</volume>
          <fpage>47</fpage>
          <lpage>54</lpage>
        </citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Lv</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Z</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population</article-title>
          <source>Ann Hepatol</source>
          <year>2012</year>
          <volume>11</volume>
          <fpage>700</fpage>
          <lpage>707</lpage>
        </citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Moore</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Baris</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Figueroa</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Garcia-Closas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Karagas</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Schwenn</surname>
              <given-names>MR</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis</article-title>
          <source>Carcinogenesis</source>
          <year>2011</year>
          <volume>32</volume>
          <fpage>182</fpage>
          <lpage>189</lpage>
        </citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Partosch</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mielke</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gundert-Remy</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Functional UDP-glucuronyltransferase 2B15 polymorphism and bisphenol A concentrations in blood: results from physiologically based kinetic modelling</article-title>
          <source>Arch Toxicol</source>
          <year>2013</year>
          <volume>87</volume>
          <fpage>1257</fpage>
          <lpage>1264</lpage>
        </citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Safarinejad</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Shafiei</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Safarinejad</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene</article-title>
          <source>Arch Toxicol</source>
          <year>2011</year>
          <volume>85</volume>
          <fpage>1209</fpage>
          <lpage>1218</lpage>
        </citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Sanderson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Salanti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis</article-title>
          <source>Am J Epidemiol</source>
          <year>2007</year>
          <volume>166</volume>
          <fpage>741</fpage>
          <lpage>751</lpage>
        </citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Santovito</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schilir&#xF2;</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Castellano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cervella</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bigatti</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Gilli</surname>
              <given-names>G</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Combined analysis of chromosomal aberrations and glutathione S-transferase M1 and T1 polymorphisms in pathologists occupationally exposed to formaldehyde</article-title>
          <source>Arch Toxicol</source>
          <year>2011</year>
          <volume>85</volume>
          <fpage>1295</fpage>
          <lpage>1302</lpage>
        </citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Selinski</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Blaszkewicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ickstadt</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hengstler</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Golka</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk</article-title>
          <source>Arch Toxicol</source>
          <year>2013</year>
          <volume>87</volume>
          <fpage>2129</fpage>
          <lpage>2139</lpage>
        </citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Selinski</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Blaszkewicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lehmann</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Ovsiannikov</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Moormann</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Guballa</surname>
              <given-names>C</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype</article-title>
          <source>Pharmacogenet Genomics</source>
          <year>2011</year>
          <volume>21</volume>
          <fpage>673</fpage>
          <lpage>678</lpage>
        </citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Selinski</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lehmann</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Blaszkewicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ovsiannikov</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Moormann</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Guballa</surname>
              <given-names>C</given-names>
            </name>
            <etal />
          </person-group>
          <article-title xml:lang="de">Rs11892031</article-title>
          <trans-title>A on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk</trans-title>
          <source>Arch Toxicol</source>
          <year>2012</year>
          <volume>86</volume>
          <fpage>1369</fpage>
          <lpage>1378</lpage>
        </citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Selinski</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lehmann</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Blaszkewicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ovsiannikov</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Moormann</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Guballa</surname>
              <given-names>C</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene</article-title>
          <source>Arch Toxicol</source>
          <year>2012</year>
          <volume>86</volume>
          <fpage>195</fpage>
          <lpage>203</lpage>
        </citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Sobin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Parisi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Schaub</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gutierrez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ortega</surname>
              <given-names>AX</given-names>
            </name>
          </person-group>
          <article-title>&#x3B4;-Aminolevulinic acid dehydratase single nucleotide polymorphism 2 and peptide transporter 2&#x2A;2 haplotype may differentially mediate lead exposure in male children</article-title>
          <source>Arch Environ Contam Toxicol</source>
          <year>2011</year>
          <volume>61</volume>
          <fpage>521</fpage>
          <lpage>529</lpage>
        </citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Stewart</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Marchan</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Polymorphisms hit the headlines</article-title>
          <source>Arch Toxicol</source>
          <year>2012</year>
          <volume>86</volume>
          <fpage>1799</fpage>
          <lpage>1801</lpage>
        </citation>
      </ref>
      <ref id="R42">
        <label>42</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Tumer</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Sahin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Arin&#xE7;</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia</article-title>
          <source>Arch Toxicol</source>
          <year>2012</year>
          <volume>86</volume>
          <fpage>431</fpage>
          <lpage>439</lpage>
        </citation>
      </ref>
      <ref id="R43">
        <label>43</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Ulusoy</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Arin&#xE7;</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Adali</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population</article-title>
          <source>Arch Toxicol</source>
          <year>2007</year>
          <volume>81</volume>
          <fpage>711</fpage>
          <lpage>718</lpage>
        </citation>
      </ref>
      <ref id="R44">
        <label>44</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Vineis</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Marinelli</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Autrup</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Brockmoller</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cascorbi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Daly</surname>
              <given-names>AK</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies</article-title>
          <source>Cancer Epidemiol Biomarkers Prev</source>
          <year>2001</year>
          <volume>10</volume>
          <fpage>1249</fpage>
          <lpage>1252</lpage>
        </citation>
      </ref>
      <ref id="R45">
        <label>45</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Zeller</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>H&#xF6;gel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Linsenmeyer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Teller</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Speit</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Investigations of potential susceptibility toward formaldehyde-induced genotoxicity</article-title>
          <source>Arch Toxicol</source>
          <year>2012</year>
          <volume>86</volume>
          <fpage>1465</fpage>
          <lpage>1473</lpage>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>